Omega Funds

About The Fund

Omega Funds is an investment fund that concentrates on the future of medicine by investing in companies operating within various healthcare sectors such as BioTech, HealthTech, Impact, Medical Devices, Healthcare and Wellness, Life Science, Consumer, and Pharmaceutical industries. They target to empower companies through investments ranging from a minimum of $100,000 to a maximum of $5,000,000, with a special focus on the investment 'sweet spot' of $1,500,000. The fund's specialties include early-stage investments, such as Seed, Series A, and Series B funding rounds. Omega Funds positions itself strategically in the market by offering the opportunity to tap into the expertise of institutional portfolio managers for a diverse investment portfolio with high return potential, starting at a minimum investment amount of $500. Their investment philosophy highlights the importance of people, products, and platforms. They are committed to investing in exceptional founders and entrepreneurs, impactful products, and innovative platforms across multiple therapeutic areas including oncology, immunology, rare diseases, and precision medicine among others. Omega Funds prides itself on contributing to the development of 50 products that have reached patients, underlining their role as an influential player in bringing scientific advancements to the market. The firm operates with the understanding that success comes from preparation and provides entrepreneurs with experience, commitment, and meaningful connections to enhance their probability of success. Omega Funds engages actively with companies and displays a readiness to discuss potential opportunities, signifying their hands-on and approachable investment ethos. The fund's presence is noted both in Boston, MA, and Geneva, Switzerland, reflecting a strong international footprint in the venture capital healthcare sector.